Social distancing reduces infections; N95 masks work best, new study finds
By
Alicia Lasek
Jun 02, 2020
The results are the “best available evidence” that coronavirus infection risk depends on distancing and PPE, say investigators.
Clinical Briefs for Wednesday, June 3
By
Alicia Lasek
Jun 02, 2020
Study shows toxic tau protein spreads in brain of older Alzheimer’s patients … Uneven handgrip strength plus weakness may predict rapid cognitive decline … Eli Lilly begins first human tests of a...
One in ten with diabetes die within week of COVID-19 hospitalization: Weight a key factor
By
Alicia Lasek
Jun 01, 2020
Researchers have linked higher BMI in diabetes to adverse COVID-19 outcomes in hospitalized patients.
Drug may hasten recovery in moderately ill COVID-19 patients
By
Alicia Lasek
Jun 01, 2020
The antiviral drug remdesivir has been shown to improve recovery time in moderate COVID-19 illness, drugmaker Gilead Sciences announced Monday.
High-quality carbs linked to lowered diabetes risk
By
Alicia Lasek
Jun 01, 2020
A new study highlights the importance of distinguishing between dietary carbohydrates from high- and low-quality sources, say investigators.
Clinical Briefs for Tuesday, June 2
By
Alicia Lasek
Jun 01, 2020
First federal count: more than 25,000 coronavirus deaths in nursing homes … AstraZeneca’s heart drug for high-risk patients receives FDA approval … Senior living operator balances safety, quality...
About 30% of senior living communities report no COVID-19 cases: survey
By
Alicia Lasek
May 30, 2020
Three in ten Ziegler survey respondents report no cases, and most say 2% or fewer residents and staff have tested positive. Meanwhile, four in ten say they’re easing lockdown restrictions.
FCC telehealth grants a ‘game changer,’ says operator awarded $910,000
By
Alicia Lasek
May 30, 2020
Eldercare and senior living facility operators are among the latest beneficiaries in a federal program to support connected care services during the pandemic.
Antidepressant fails to improve apathy in Alzheimer’s patients
By
Alicia Lasek
May 30, 2020
Bupropion had no effect in the largest trial yet to study apathy treatment in Alzheimer’s, say investigators.
Clinical Briefs for Monday, June 1
By
Alicia Lasek
May 30, 2020
Non-stop COVID-19 testing ‘a pathway through the fog,’ says D.C. nursing home operator … CDC: Antibody tests not yet accurate enough for use in coronavirus policy-making … Patients with cancer...